Over the past five years, Sanofi has invested approximately 3.5 billion pesos to strengthen its infrastructure in the state of Mexico.

Novartis Pharmaceutical Research Laboratories It has been continuously strengthening its presence in the State of Mexico, where it has 3 production plants and a distribution center.

Headquartered in Basel, Switzerland, the laboratory has significant operations in 155 countries, considers our country as a global strategic market, and has one of the 6 Novartis Corporate Centers (English acronym for NOCC), where procurement and procurement are located. Centralization of supply teams and processes, Real estate and facilities, data digital and IT, Human resources as well as business, medical, scientific, quality, legal and consulting services are provided, in addition to the financial, legal and communications functions in the region.

Thanks to the industrial capabilities of the Mexican entity, as well as the professional work and dedication of 1,500 collaborators from 10 countries serving different areas of the company, Novartis produces more than 200 million units of medicines per year, accounting for 85% of global pharmaceutical production %. Of which for domestic consumption, the remaining 15% for export.

Currently, approximately 40% of employees work at the Ocoyoacac and Cuautitlán Izcalli plants, with very low turnover and significant gender equality, as both of the company’s plants are headed by female executives, in addition to 50% of its human capital being women.

Source link

Leave a Comment